خط إنتاج شركة هاليا ثيرابيوتكس:

Halia is committed to developing novel, meaningful medicines for patients with serious diseases who may benefit from new treatment options. Halia’s current policy for evaluating and responding to requests for individual patient access to investigational drugs intended to treat serious diseases is found below.

Our product pipeline consists of investigational medications currently being tested in clinical trials and have not yet been approved by the US Food and Drug Administration (FDA). Halia’s investigational drugs are currently at an early stage in development, and we are is currently focused on enrolling patients in our clinical trials and continuing to learn more about our investigational drugs’ safety and efficacy. We encourage patients to speak with their physicians about their eligibility for enrollment in any of Halia’s clinical trials whenever possible. Our clinical trials are designed, conducted, and monitored to advance the development of our investigational drugs and make them more broadly available to patients in the future. Additional information about Halia’s ongoing clinical trials is available at https://clinicaltrials.govusing the search term “Halia.”

لون ليبسوم من لوريم يناسب النخبة المكرّسة والمخلصة. قم بتعليق العديد من العناصر في العنصر الثلاثي الخاص بك. دوران، أريد أن أعيش من جديد، لن يكون هناك أي ألم مؤقت، ولكن يمكنني الحصول على حياة حرة. حبوب منع الحمل ليست خالية تمامًا من الدهون في الفم. الآن يجب أن تكون سيرتك الذاتية محفوفة بالمخاطر.info@haliatherapeutics.com. Halia personnel will acknowledge receipt of any expanded access questions within ten business days of receipt. For additional information on expanded access to investigational drugs, visit the FDA’s website.